Open access
67
Views
29
CrossRef citations to date
0
Altmetric
Original Research
Effect of verapamil on systemic exposure and safety of umeclidinium and vilanterol: a randomized and open-label study
Rashmi Mehta1 Respiratory Medicines Development Center, GlaxoSmithKline, Research Triangle Park, NC, USACorrespondence[email protected]
, Dennis Kelleher1 Respiratory Medicines Development Center, GlaxoSmithKline, Research Triangle Park, NC, USA
, Andrew Preece2 Respiratory Medicines Development Center, GlaxoSmithKline, Stockley Park West, UK
, Stephen Hughes3 GlaxoSmithKline R&D, Bioanalytical Sciences and Toxicokinetics, Drug Metabolism and Pharmacokinetics, Ware, UK
& Glenn Crater4 Respiratory Medicine Development Center, GlaxoSmithKline, Mississauga, ON, Canada
Pages 159-167
|
Published online: 27 Mar 2013
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.